Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’ ; volume:14 ; number:1 ; day:25 ; month:3 ; year:2014 ; pages:1-10 ; date:12.2014
BMC cancer ; 14, Heft 1 (25.3.2014), 1-10, 12.2014
- Urheber
-
Kotsopoulos, Joanne
- Beteiligte Personen und Organisationen
-
Metcalfe, Kelly
Alston, Jill
Nikitina, Dina
Ginsburg, Ophira
Eisen, Andrea
Demsky, Rochelle
Akbari, Mohammad
Zbuk, Kevin
Narod, Steven A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-221
- URN
-
urn:nbn:de:1111-2016030414893
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kotsopoulos, Joanne
- Metcalfe, Kelly
- Alston, Jill
- Nikitina, Dina
- Ginsburg, Ophira
- Eisen, Andrea
- Demsky, Rochelle
- Akbari, Mohammad
- Zbuk, Kevin
- Narod, Steven A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
BRCA1 mutation in the Triple- Negative Breast Cancer Group
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Mutationsanalyse im NBS1-Gen bei Patientinnen mit BRCA1/2 negativem familiären und BRCA1/2 negativem sporadischen Mammakarzinom
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Methylierungsanalysen des BRCA1-Gens beim tripel-negativen Mammakarzinom
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
BRCA1 mutation in the Triple- Negative Breast Cancer Group
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Mutationsanalyse im NBS1-Gen bei Patientinnen mit BRCA1/2 negativem familiären und BRCA1/2 negativem sporadischen Mammakarzinom
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Methylierungsanalysen des BRCA1-Gens beim tripel-negativen Mammakarzinom
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
BRCA1 mutation in the Triple- Negative Breast Cancer Group
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Mutationsanalyse im NBS1-Gen bei Patientinnen mit BRCA1/2 negativem familiären und BRCA1/2 negativem sporadischen Mammakarzinom
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Methylierungsanalysen des BRCA1-Gens beim tripel-negativen Mammakarzinom